drugset / Trial / NCT04832139
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device
RandomizedCrossoverOpen-labelBasic science
Summary
The goal in this study is to show that there are not significant differences in biologic activity of the study drug when administered using either the prefilled pen and prefilled syringe.
Timeline
- Start
- 2021-03-30
- Primary completion
- 2021-11-22
- Completion
- 2021-11-22
Outcome
Outcome not reported
Stopped: “The study was terminated due to a change in the benefit/risk assessment for the further administration of marstacimab in a healthy volunteer population.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Marstacimab | Monoclonal antibody | 300 mg | Subcutaneous |
Indications
No indication recorded.